{
    "Trade/Device Name(s)": [
        "CrAg Lateral Flow Assay",
        "Cryptococcal Antigen Lateral Flow Immunoassay"
    ],
    "Submitter Information": "Immuno-Mycologics, Inc.",
    "510(k) Number": "K102286",
    "Predicate Device Reference 510(k) Number(s)": [
        "K791382"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GMD"
    ],
    "Summary Letter Date": "July 20, 2011",
    "Summary Letter Received Date": "July 19, 2011",
    "Submission Date": "July 18, 2011",
    "Regulation Number(s)": [
        "21CFR866.3165"
    ],
    "Regulation Name(s)": [
        "Cryptococcus neoformans serological reagents"
    ],
    "Analyte Class(es)": [
        "mycology",
        "serology"
    ],
    "Analyte(s)": [
        "Cryptococcal capsular polysaccharide antigen"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Test tube",
        "Microtiter plate"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Sandwich immunoassay",
        "Dipstick lateral flow"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Reagent",
        "Strip test",
        "Dipstick"
    ],
    "Document Summary": "FDA 510(k) summary for CrAg Lateral Flow Assay, a lateral flow immunoassay for qualitative or semi-quantitative detection of cryptococcal antigen in serum.",
    "Indications for Use Summary": "Qualitative or semi-quantitative detection of capsular polysaccharide antigens of Cryptococcus neoformans and Cryptococcus gatti in serum to aid in diagnosis of cryptococcosis.",
    "fda_folder": "Microbiology"
}